header
Image from OpenLibrary

Infliximab therapy in ocular manifestations of behcet's disease / Sherif Ahmed Shawky ; Supervised Ayman Elgarf , Amira Abdelsaboor Shahin

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Sherif Ahmed Shawky , 2012Description: 135P. : charts , facsimiles ; 25cmOther title:
  • تأثير عقار الأنفليكسيماب على أمراض العين المصاحبة لمرض بهجت [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilition Summary: This study was designed to assess the efficacy and safety of Infliximab (IFX) in the treatment of ocular manifestation in patients with Behcet's disease , namely BD-associated refractory posterior uveitis (PU) as expressed by VA improvement from baseline and to investigate the efficaey of IFX to reduce disease flare-up , to assess the proportion of relapse free subjects at the end of follow-up and the pereentage of patients achieving a complete or partial remission and to evaluate the tolerability and safety of the treatment
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.32.Ph.D.2012.Sh.I (Browse shelf(Opens below)) Not for loan 01010110058959000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.32.Ph.D.2012.Sh.I (Browse shelf(Opens below)) 58959.CD Not for loan 01020110058959000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilition

This study was designed to assess the efficacy and safety of Infliximab (IFX) in the treatment of ocular manifestation in patients with Behcet's disease , namely BD-associated refractory posterior uveitis (PU) as expressed by VA improvement from baseline and to investigate the efficaey of IFX to reduce disease flare-up , to assess the proportion of relapse free subjects at the end of follow-up and the pereentage of patients achieving a complete or partial remission and to evaluate the tolerability and safety of the treatment

Issued also as CD

There are no comments on this title.

to post a comment.